Stay updated with breaking news from Nasdaq Beam. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Beam Therapeutics (NASDAQ:BEAM – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $1.73 EPS for the quarter, topping the consensus estimate of ($0.69) by $2.42, Briefing.com reports. Beam Therapeutics had a negative net margin of 35.09% and a negative return on equity of 16.90%. The firm had revenue of $316.20 […]
Beam Therapeutics (NASDAQ:BEAM – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.69) by $2.42, Briefing.com reports. The company had revenue of $316.20 million for the quarter, compared to analysts’ expectations of $34.16 million. Beam Therapeutics had […]
Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a note issued to investors on Tuesday, RTT News reports. They presently have a $57.00 price objective on the stock, up from their prior price objective of $48.00. Wedbush’s price objective would suggest a potential upside of […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) fell 8.9% during mid-day trading on Tuesday . The company traded as low as $30.30 and last traded at $30.44. 405,654 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 1,195,352 shares. The stock had previously closed at $33.40. Analysts […]
Capula Management Ltd bought a new stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 38,100 shares of the company’s stock, valued at approximately $916,000. A number of other hedge […]